Gregg Nyberg
Chief Technology Officer • Landmark Bio
Gregg Nyberg, Ph.D., brings more than 20 years’ biopharmaceutical industry experience to his new role at Landmark Bio. Most recently, he was associate vice president at Merck, where he led the company’s biologics process development and clinical manufacturing organizations. He also spent nearly 15 years in positions of increasing responsibility at Amgen including key leadership roles in process development and cell sciences and technology.
Dr. Nyberg earned a Ph.D. in chemical engineering from the Massachusetts Institute of Technology and a B.S. in chemical engineering and petroleum refining from the Colorado School of Mines.
Also Speaking
Fran Gullo
Scientific Director, Gift of Life Center for Cell and Gene Therapy • Gift of Life Biologics
9 November 2022
Konstantina Katcheves
Senior Vice President Business Development • Bristol Myers Squibb
28 December 2022
Also Speaking
Investor List
Take a look at some of the investors who attended Advanced Therapies Week 2023.
6 January 2023
